Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD<sub>GBA</sub>Stefanie Lerche, Claudia Schulte, Isabel Wurster, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Journal of Parkinson'S Disease|January 24, 2022
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's DiseaseJennifer Michels, Hendrik van der Wurp, Elke Kalbe, et al.
Translational Neurodegeneration|April 16, 2019
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptorsFranziska Hopfner, Stefanie H Müller, Dagmar Steppat, et al.
Nature Medicine|July 15, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Rowan Saloner, Jacob W Vogel, et al.
Pageof 13